Limited information exists on whether ventricular tachycardia or fibrillation (VT/VF) affects the prognosis of patients undergoing percutaneous coronary intervention (PCI). After performing a ...

January 29, 2004 — Are the doldrums of winter bringing you down? Apparently, they may be doing more than just affecting the psyche. Dirk Müller, MD, Free University (Berlin, Germany), and colleagues ...

Presenting data last week at the American Heart Association 2006 Scientific Sessions, lead investigator Dr Christine Albert (Harvard Medical School, Boston, MA) and colleagues report that acute ...

Certain heart attack patients who experience a rapid, abnormal heart rhythm before or after a coronary artery intervention or stent placement have a significantly higher risk of death within 90 days ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Primary prevention implantable cardioverter-defibrillators (ICDs) equipped for antitachycardia pacing (ATP) offered fewer first device shocks but perhaps at a cost, the APPRAISE ATP randomized trial ...

Pulseless ventricular tachycardia (VT) is an atypical heart rhythm that can cause chest pain, fainting, and cardiac arrest. Doctors treat it with cardiopulmonary resuscitation, defibrillators, and ...

Lidocaine is a class IB antiarrhythmic drug used for the treatment of ventricular arrhythmias, specifically ventricular tachycardia and ventricular fibrillation. Lidocaine blocks cardiac sodium ...

Last time, I started talking about how on TV shows, defibrillating the heart with the wired-up paddles always works beautifully, after the heart monitor has gone flat, emitting only a mournful ...